Independent information services
Practical guides, comparison tools, research summaries, and question frameworks for people trying to understand how ibogaine treatment in Costa Rica is described—and what those descriptions may leave uncertain.
Still Threshold 23 provides information, not treatment, referral, medical advice, or travel recommendations.
A clear starting point
Our overview of ibogaine treatment in Costa Rica begins with the basic claims people encounter, then keeps the focus on evidence, serious safety questions, screening, and oversight uncertainty.
For the purpose and limits behind this work, see how Still Threshold 23 approaches independent information. The goal is not to direct anyone toward a provider; it is to make evaluation more careful and more legible.
Four information services / one standard: safety before claims
Plain-language guides map the usual stages described around ibogaine treatment, including preparation, screening claims, acute effects, observation, and aftercare. They distinguish what is commonly said from what is established.
Question frameworks help readers identify the details that matter before accepting broad assurances: medical history, medication interactions, emergency planning, follow-up, and what remains unknown.
Comparisons clarify terms that can be used loosely in treatment marketing, while a glossary puts clinical, legal, and research language into direct, usable wording.
Research summaries and FAQ collections organize evidence limits, reported risks, and the questions families often face when trying to separate hopeful claims from supportable conclusions.
Evidence, without overstatement
Ibogaine is a psychoactive substance, and its use has been associated with serious medical concerns. The FDA warning on serious risks associated with ibogaine describes potentially dangerous effects including cardiac complications.
Our summaries use careful language around what research does and does not establish. For basic context, the background on ibogaine can help explain why safety, pharmacology, and legal status require separate questions rather than one broad conclusion.
A deliberate reading path
“A useful guide does not turn uncertainty into reassurance. It makes the unanswered questions visible.”
Common boundaries
No. Still Threshold 23 is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its material is not medical or legal advice, and it does not replace individualized guidance from qualified professionals.
Ibogaine can carry serious risks, and the available evidence does not erase those risks. The guides help readers recognize the questions that deserve careful, qualified answers rather than presenting ibogaine as a proven cure.
No. The material is intended for people already researching claims about ibogaine treatment in Costa Rica. It does not endorse a provider, recommend travel, or evaluate a specific treatment center.
Keep the questions in view
Information can clarify a decision, but it cannot substitute for qualified medical assessment. Use the resource to identify what needs independent verification.
Review the medical risk brief